- Life Sciences
The COVID-19 pandemic has changed the world beyond imagination. For the pharma industry, the last few months have been nothing but a roller coaster ride. As the industry is undergoing a profound transformation, the need for a new approach becomes imperative.
In our latest edition of Perspectives, which was the first-ever LinkedIn Live Session hosted by Infosys on New Opportunities and Challenges in the Pharma Industry , our esteemed speakers Subhro Mallik, Senior Vice President and Global Head, Life Sciences, Infosys and Saurabh Gupta, Chief Research Officer, HFS share their perspectives about the long-term impact of COVID-19 on the global pharma industry, how to bring more resilience into the system and what lies ahead.